NeuroStar Advanced Therapy

Jul 08, 2019

NeuroStar® Patient Outcomes Registry Has Now Surpassed 3,000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder

Nov 13, 2018

NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment

Oct 11, 2018

NeuroStar® Advanced Therapy Hits 2 Million Treatments During National Depression Awareness Month

May 14, 2018

Boston TMS Therapy Center Earns NeuroStar® Gold Circle Provider Status

May 05, 2018

NeuroStar® Advanced Therapy Reaches Monumental Milestone of 1.7 Million Treatments in the US

Oct 16, 2017

Neuronetics, Inc. Partners with Teijin Pharma Limited, a Leading Healthcare Company in Japan, to Distribute NeuroStar Advanced Therapy

Oct 11, 2017

NeuroStar® Advanced Therapy Approved as a Life-Changing Depression Treatment to Help Conquer Depression in Japan

Jun 06, 2017

Neuronetics, Inc. Raises $15 Million in Series G Equity Financing, Led by Ascension Ventures